A Study of the Clinical Efficacy and Safety of 20% Cassia Alata Extract Against Tinea Versicolor

Recruiting now · Phase 1

Conditions studied: Tinea Versicolor, Pityriasis Versicolor

In brief

The goal of this clinical trial is to establish the efficacy of Cassia alata extract as a cream form in treating tinea versicolor (liver spots/shifting clouds). The main questions the study aims to answer are:• Does the use of this extract help resolve tinea versicolor better than no treatment? Does the use of this cream have significant side effects i.e, is it safe? Participants will be asked to treat a designated area while leaving additional areas untreated. 1-2 finger tip units of cream will be applied to the treatment site twice daily at least 8 hours apart. Participants will attend the trial clinic every 4 weeks for 12 weeks.

Key facts

Study ID: NCT05730244
Run by: The University of The West Indies
People needed: 20
Starts: 2025-03-01
Expected to finish: 2026-12-30
Last updated by the study team: 2025-11-19

Who can join

Age: 18 and older, up to 89. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Patients aged 18-89 of either sex
Clinical features suggestive of tinea versicolor AND Microscopic confirmation using skin scraping stains with chlorazol black preparation AND/OR Wood's lamp fluorescence
No treatment for versicolor in the preceding 4 weeks
No contraindications to the application of C.alata cream including
No history of allergy to C. alata
No history of preservative allergy

You may not qualify if…

Age <18 or >89 years
Pregnant females
History of hypersensitivity to C. alata or preservative
Treatment within 4 weeks prior to enrollment
Lesions which do not meet the diagnostic criteria of tinea versicolor

Where it is running

University of the West Indies, Mona — Kingston, Other, Jamaica (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.